images reconstructed with high-spatial-frequency algorithms provide more accurate volumetric quantification of pulmonary nodules, including GGOs (16, 18) .
In addition to volume, de Hoop et al. (19) developed a quantitative method to measure the growth rate of GGOs on the basis of the concept of mass, calculated by multiplying the nodule volume by the mean nodule density (i.e., mean CT number+1000). In their experience, mass and not volume should be the preferred parameter for the evaluation of growth in GGOs.
Recently, Song et al. (20) demonstrated that volume-DTs and mass-DTs were significantly longer in pure and part-solid GGOs with a solid component of ≤5 mm than in part-solid GGOs with a solid component of >5 mm. Furthermore, Oda et al. (21) reported that volume-DT may be helpful in differentiating the histologic entities of GGOs.
Although the natural history and growth rate of the various lesions along the adenocarcinoma spectrum have been previously studied (6, 7, (22) (23) (24) (25) , to the best of our knowledge, there are no published studies in which the volume and mass changes of pulmonary adenocarcinomas with GGOs (and their respective DTs) have been investigated using 3D software for each CT performed throughout follow-up (not just the baseline and last CT scan). Therefore, this study aimed to explore the growth pattern and rate of a group of pulmonary adenocarcinomas appearing as GGOs that were retrospectively analyzed with 3D commercial software to further understand their natural volumetric behavior. We also evaluated the intra-and interobserver variabilities in volume, mass, and DT measurements as well as the relationship between DTs, histopathologic diagnosis, and initial CT features.
Methods

Patients and GGO lesion selection
Through a search on the department RIS/ PACS between January 2004 and December 2014, all CT reports containing findings suggestive of persistent GGOs, i.e., focal groundglass (or sub-solid) lesions unchanged or increased in size during a three-month or longer follow-up, were retrieved; both part-solid and pure GGOs were considered.
The search identified a total of 271 patients with one or more persistent GGOs. The study sample was selected according to the following inclusion criteria: a) GGO diameter (i.e., mean between the longest horizontal axis and its perpendicular diameter on the largest cross-sectional area of the lesion) of ≥8 mm; b) two or more multidetector CT scans performed with the same scanner and same acquisition/reconstruction protocol; c) thin-section 1 mm axial lung window images in DICOM format available; and d) histologic diagnosis made from surgical resection specimen according to the International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society (IASLC/ATS/ERS) classification of lung adenocarcinoma (26) .
Patients with interstitial pneumonia, a history of pulmonary aspergillosis, eosinophilic pneumonia, organizing pneumonia, or undergoing steroid or chemotherapy treatment were excluded.
Applying such criteria, a total of 22 pulmonary adenocarcinomas exhibiting GGOs were enrolled in the study, including 19 patients (12 males, 7 females) aged 49-84 years (mean, 67.4±10.4 years); three patients had two GGOs. The smoking habits and oncologic history of the 19 patients are listed in Table 1 .
Image acquisition
Seventeen GGOs were scanned on a 16-detector CT scanner (Somatom Sensation 16; Siemens) with the following parameters: collimation, 16×0.75 mm; beam pitch, 1.0; rotation time, 0.5 s; tube voltage, 120 kVp; and tube current, 180 mAs. The remaining five GGOs were scanned using a 128-detector CT scanner (Somatom Definition Flash; Siemens) with the following parameters: collimation, 128×0.6 mm; beam pitch, 1.2; rotation time, 0.5 s; tube voltage, 120 kVp; and tube current, 110 mAs.
The acquisition, extending from the lung apex to lung base, was performed in inspiratory apnea without spirometric control of the lung volume. The volume was reconstructed as 1 mm thick sections, applying a sharp reconstruction algorithm and preset windowing, suited for lung parenchyma assessment.
Main points
• Appropriate knowledge of growth patterns and rates of pulmonary adenocarcinomas presenting as ground-glass opacities (GGOs) is an important issue in the management of GGO lesions.
• Three-dimensional measurements are the current method of choice in the assessment of the growth rate of pulmonary nodules (including GGOs) by calculating volume and/or mass changes and their respective doubling times.
• Our three-dimensional analysis shows that pulmonary adenocarcinomas exhibiting GGOs have different patterns of growth: some lesions grow rapidly and some grow slowly, whereas others alternate between periods of growth, stability or shrinkage during follow-up.
• Volume and mass doubling times do not correlate with the initial CT features of the GGOs; however, they may provide information on GGO aggressiveness. 
Computerized 3D analysis
The axial diameters, mean CT attenuation, volume and mass changes of GGOs, and their volume-DT and mass-DT were calculated by matching the baseline and each consecutive CT scan using 3D semiautomatic software (SAT module, classic version; Terarecon, Inc. ), which allows for the manual delineation and correction of nodule contours (Fig. 1) . When the segmentations of two follow-up CT scans are matched, their results are simultaneously displayed and analyzed by the 3D software (Fig. 2) .
Segmentation processing and 3D analysis were assessed visually and considered successful when the GGO was completely outlined without any segmentation errors. A threshold attenuation value of −850 HU was used as the lower limit for GGO segmentation (27) .
The diameter of each GGO at the baseline and at the last CT scan was determined by calculating the average of two diameters generated by the software at the end of segmentation ( Figs. 1 and 2) .
The mass was calculated by multiplying the GGO volume by the mean nodule density (i.e., mean CT number + 1000). Mass changes and mass-DT were calculated only in the GGOs in which CT scans had been acquired without contrast.
Prior to the 3D analysis, visual assessment of the presence or absence of a solid component within the GGO was performed at the baseline and at the last CT scan.
The 3D analysis and visual assessment of the solid component within GGOs were performed by a radiologist with 11 years of experience in thoracic imaging and five years of experience in using the software.
To assess variability of measurements, after an interval of at least six months, the same observer and another radiologist (with 15 years of experience in CT imaging and three years of experience in using the software) independently repeated the volume, mass, and DT measurements at the baseline and at the last CT scan of the GGOs in which both scans were performed without contrast.
For each GGO, the minimum time interval required to detect a significant growth (i.e., exceeding the interobserver coefficient of repeatability for the volume and mass measurements) was also calculated.
The study was approved by the local ethics committee as a retrospective analysis. It did not alter the management of the patients, thus no specific consent was required. However, informed consent had been obtained at the follow-up steps for both the CT scanning and the treatment of personal data.
Statistical analysis
The data are presented as the number (%) or the mean ± standard deviation for normally distributed data or as the median and the interquartile range (IQR) for not normally distributed data.
Bland-Altman analysis was used to determine the intra-and interobserver variability of the volume, mass, and DT measurements. For the intra-and interobserver variability, the relative differences in measurements were expressed as the percentage of the differences for each pair of measurements divided by the mean of two measurements (without log transformation). The limits for the percentage differences were presented as 95% confidence intervals. For interobserver variability, the first measurement of the first observer was used.
We used the percentage rather than the absolute differences, as proposed originally by Bland and Altman (28) , because the differences in measurements are not independent of the magnitude of the measurements. From the Bland-Altman analysis, we also obtained the coefficient of repeatability (CR) (28) , which was calculated as 1.96 times the standard deviation of the differences between the measurements and which is a measure of the 95% limit of agreement. In fact, the CR provides a value below which the differences between two repeated measurements would fall with a probability of 95%. Therefore, only differences above the CR should be considered significant.
To compare the measurement variability, the intraobserver and interobserver coefficients of variation (CVs) for the volume, mass, and DTs were calculated for each GGO, and the Wilcoxon matched-pairs test was used to analyze the differences.
The Mann-Whitney U-test was used to compare the DTs of pure and part-solid Analysis of GGO growth pattern and doubling time by multidetector CT • 527 Figure 1 . Axial CT images show the semiautomatic segmentation process of a ground-glass opacity (GGO).
Step 1: select the lesion with a mouse click; an initial segmentation is automatically performed by the software.
Step 2: choose a threshold CT attenuation value suited for GGOs (-850 HU as the lower limit in this study) and manually outline the lesion contours on all axial CT images.
Step 3: check and correct any segmentation errors (arrow) with an editing tool.
Step 4: the segmentation is completed, and the software automatically calculates the volume, diameters (i.e., the longest and widest perpendicular diameter on the largest cross-sectional area of the lesion), and 3D mean CT attenuation of the lesion.
GGOs (calculated by matching the baseline and the last CT scan) and to analyze differences between the histologic subtypes. The Spearman correlation coefficient was applied to find correlations between the DT and CT features of GGOs (i.e., diameter, volume, mean CT attenuation, and mass) calculated on the baseline CT scan. For statistical analyses of the relationship between DTs, histopathologic diagnosis, and initial CT features, we considered only GGOs with positive DT values (calculated by matching the baseline and last CT scan).
We applied these tests because the volume, mass, and their respective DTs were not normally distributed.
Statistical analysis was performed with dedicated software (MedCalc Software). P values of <0.05 were considered statistically significant.
Results
All GGOs were histologically proven to be pulmonary adenocarcinomas: of 22 pulmonary adenocarcinomas three were adenocarcinoma in situ (AIS, 13.6%), five were minimally invasive adenocarcinoma (MIA, 22.7%), and 14 were invasive adenocarcinoma (IA, 63.6%).
Each GGO was scanned 2-6 times (mean, 3.5±1.3 times) before histologic diagnosis; 16 GGOs (72.7%) were monitored more than twice. In 19 GGOs (86.4%), all the CT studies (baseline and each follow-up CT scan) were acquired without contrast, and in 14 of 19 GGOs (73.7%), three or more follow-up CT scans were available.
The time interval between the baseline and last CT scan ranged from 126 to 1128 days (median, 573 days; IQR, 256-823 days). The time interval between two consecutive CT examinations ranged from 61 to 670 days (median, 181 days; IQR, 123-279.8 days).
At the baseline CT, seven lesions (31.8%) were classified as pure GGOs and 15 (68.2%) were classified as part-solid GGOs; two pure GGOs developed a solid component during the follow-up period ( Table 2 ). The diameter of GGOs ranged from 8 to 62 mm (median, 16.5 mm; IQR, 12.9-31 mm) at baseline and from 12.5 to 63.7 mm (median, 20.8 mm; IQR, 14.4-34.7 mm) at the last CT scan (Table 2) .
For volume measurements, intraobserver variability ranged from -19.3% to 14.3% (CR=16.8%) and interobserver variability ranged from -25.6% to 14.9% (CR=20.2%); for mass measurements, intraobserver variability ranged from -13.4% to 11.1% (CR=12.2%) and interobserver variability ranged from -20.4% to 12.4% (CR=16.4%) (Fig. 3) . The intraobserver CV for mass was significantly lower than the CV for volume (median, 0.02; IQR, 0.01-0.04 vs. median, 0.03; IQR, 0.02-0.05; P = 0.006). Similarly, the interobserver CV for mass was significantly lower than the CV for volume (median, 0.02; IQR, 0.01-0.05 vs. median, 0.03; IQR, 0.01-0.06; P = 0.020).
For volume-DT, the intra-and interobserver variability ranged from -47.5% to 46.2% (CR=46.8%) and from -51.2% to 62.8% (CR=57%), respectively; for mass-DT, the intra-and interobserver variability ranged from -55.5% to 54.8% (CR=55.1%) and from -63.2% to 48.5% (CR=55.8%), respectively (Fig. 4) .
No significant difference was observed between the intraobserver CV for the volume-DT and mass-DT (median, 0.09; IQR, 0.04-0.15 vs. median, 0.06; IQR, 0.02-0.16; P = 0.551). Similarly, no significant difference was observed between interobserver CV for the volume-DT and mass-DT (median, 0.09; IQR, 0.04-0.14 vs. median, 0.09; IQR, 0.04-0.16; P = 0.899).
Segmentation and 3D computerized analysis were successfully performed in all cases. Based on the calculated volume and mass changes and their respective DTs on each follow-up CT scan, the 3D analysis of lesions included in this study revealed that pulmonary adenocarcinomas presenting as GGOs exhibited different patterns of growth; some lesions grew rapidly and some grew slowly, whereas some alternated between periods of growth, stability or shrinkage (Figs. 5, 6 ). The volume-DTs and mass-DTs calculated on each follow-up CT scan ranged from -4293 to 21928 days and from -3113 to 17020 days, respectively (Figs. 5, 6 ). A significant increase in volume that exceeded the CR of interobserver variability (i.e., more than 20.2%) between the baseline and last CT scan was observed in 16 GGOs (72.7%; 3 pure and 13 part-solid). In this group exhibiting growth, including one AIS, two MIA, and 13 IA, the mean volume-DT ranged from 259 to 2196 days (median, 728.5 days; IQR, 460.5-952.5 days), and the minimum time interval to detect the growth ranged from 39 to 560 days (median, 170 days; IQR, 101-256 days) ( Table 2 ). In the remaining two part-solid GGOs (MIA and IA at histology) and four pure GGOs (2 AIS and 2 MIA at histology), the 3D computerized analysis did not detect a significant change in volume after a mean time interval of 349±387.2 days. In this group, only one GGO (pure, AIS at histology) decreased in volume lower than the interobserver CR (2% after an interval of 126 days). The other five GGOs increased in volume by 4%-16% (volume-DT from 960 to 5968 days).
In the subgroup of 19 GGOs (6 pure and 13 part-solid) scanned without contrast, the mean CT attenuation of GGOs ranged from -602.5 to -144.4 HU (mean, -381.7±133.6 HU) at baseline and from -615.2 to -86.3 HU (mean, -332.4±160.7 HU) at the last CT scan (Table 3) . For each lesion, changes in mean CT attenuation throughout the follow-up period are depicted in Fig. 7 . In this subgroup, a significant increase in mass that exceeded the CR of interobserver variability (i.e., more than 16.4%) between the baseline and last CT scan was observed in 16 GGOs (84.2%; 5 pure and 11 part-solid). In this group exhibiting growth, including one AIS, three MIA, and 12 IA, the mean mass-DT ranged from 226 to 4296 days (median, 844 days; IQR, 410.5-1063 days), and the minimum time interval to detect the growth ranged from 25 to 1008 days (median, 183.5 fays; IQR, 87.5-241.5 days). In the remaining two part-solid GGOs (MIA and IA at histology) and one pure GGO (AIS at histology), the 3D computerized analysis did not detect a significant change in mass after a mean time interval of 148.7±28.7 days. In this group, only one GGO (pure, AIS at histology) decreased in mass lower than the interobserver CR (2% after an interval of 126 days). The other two GGOs increased in mass by 7% and 9% with a mass-DT of 1963 and 1148 days, respectively.
No significant difference was observed between the volume-DT of pure and part-solid GGOs, as classified on the baseline CT (P = 0.392); however, the volume-DT of IA was Analysis of GGO growth pattern and doubling time by multidetector CT • 529 
Discussion
Appropriate knowledge of growth patterns and rates of pulmonary adenocarcinomas manifesting as GGOs is an important issue in lung cancer screening and impacts guidelines for nodule management (29, 30) . Many studies on the natural history of GGOs are based on changes of the longest diameter measured on 2D axial CT scan, and DTs have been calculated by applying the modified Schwartz formula (6, 7, 24, 25) . In two recent studies, the majority of GGOs (73.7% and 85.4%, respectively) did not grow during a long-term follow-up of more than two years (24, 25) .
However, some malignant lesions have asymmetric growth, resulting in minimal changes in the longest diameter but an increase in the overall volume (14) . Therefore, only 3D computerized analysis should be considered sufficiently accurate for assessing the growth pattern and calculating DTs in pulmonary lesions (13, 14) .
This observation is clearly illustrated in one of our GGOs in which 3D analysis, performed by matching the baseline and 823-day follow-up CT scan, exhibited a relative volume variation of 44% without a significant change in the axial diameters (Fig. 2) .
Initial studies on computerized volumetric analysis performed on chest phantoms demonstrated a significantly higher measurement inaccuracy in GGOs than in solid nodules (16) . The segmentation of GGOs is hampered by the small density gap between the lesion and surrounding normal parenchyma. In addition, volumetric analAnalysis of GGO growth pattern and doubling time by multidetector CT • 531 ysis may be influenced by the 3D software utilized, size of the lesion, scanning and reconstruction protocols, and depth of the patient's inspiration (14) (15) (16) 31 ).
However, relatively recent studies demonstrated that volumetric analysis may play a significant role in GGO monitoring (17, 18 ). Oda et al. (17) showed promising results on the accuracy and reproducibility of volumetric analysis of GGOs ≥8 mm. Nonetheless, the intra-and interobserver variability were higher than those in studies on solid nodules (13) . A newly developed method to assess the growth rate of GGOs is through the calculation of the mass; this parameter is considered advantageous for GGO monitoring because it combines volumetric and densitometric evaluation and is subject to less variability than volume (19) .
In our study, all GGOs were successfully segmented despite the difficulties reported in the literature (16) . Our intra-and interobserver variability were greater than those reported by Kim et al. (32) using commercial semiautomatic software without manual editing and margin drawing. In their study, intraobserver volume and mass measurement variability for reader 1 ranged from -7.6% to 8.5% and from -8.1% to 8.7%, respectively, whereas interobserver volume and mass measurement variability ranged from -11.7% to 18.1% and from -17.5% to 11.8%, respectively. Such differences are likely to be related to the influence of manual correction used in our segmentations. However, in clinical practice, the variability of measurements after manual editing may be reduced because the baseline and follow-up CT scan are simultaneously displayed by software (Fig. 2) ; therefore, differences between the two segmentations may be promptly identified and corrected.
Our interobserver variability for volume and mass measurements was lower than that recently reported by Scholten et al. (33) using semiautomatic segmentation software with an editing tool. In their study, interobserver volume and mass measurement variability ranged from -64.4% to 72.1% and from -43.4% to 53.4%, respectively. Their results may be mainly affected by the algorithm selected for CT image reconstruction (moderately soft kernel) (16, 18 ) and the significant difference in experience of the two observers (greater than that in our study).
With regard to the CV comparison, Kim et al. (32) found no significant difference between volume and mass measurement variability. Conversely, our results demonstrate that mass measurements are subject to less variability than volume measurements, in line with previous data reported by de Hoop et al. (19) using in-house manual software; however, our intra-and interobserver CVs were lower than those reported by de Hoop et al. (19) . This difference may be related to the type of 3D software used (semiautomatic vs. manual), the algorithm selected for CT image reconstruction (sharp vs. moderately soft kernel) (16, 18) , and the size of GGOs analyzed (larger in our study) (17) .
We also found that the intra-and interobserver variability in volume-DT and mass-DT measurements (not previously reported) were moderately high (Fig. 4) , and there was no significant difference between their CVs.
To the best of our knowledge, this study is the first in which 3D analysis of growth patterns and the rates of a group of pulmonary adenocarcinomas presenting as GGOs was performed using commercial semiautomatic software while considering each CT performed during follow-up (not just the baseline and last scan). This analysis allowed us to demonstrate that adenocarcinomas showing GGOs have different growth patterns and rates (Figs. 5, 6 ), which were not correlated with the majority of initial CT features, such as nodule consistency (pure or part-solid), diameter, volume, mean CT attenuation, and mass. In fact, some GGOs grew faster (time intervals to detect growth for volume and mass measurements of 39 and 25 days, respectively) and some grew more slowly (time intervals to detect growth for volume and mass measurements of 560 and 1008 days, respectively), whereas others alternated between periods of stability, growth, or shrinkage with or without a significant increase in size during follow-up. Furthermore, the volume-DTs and mass-DTs of some GGOs varied considerably throughout the follow-up period (Figs. 5, 6 ).
These different growth patterns and rates might be due to various factors: interscan differences (i.e., variable degrees of inspiratory apnea, patient position, intraobserver variability), which might justify the variation of measurements in some cases (32, 34) ; alveolar collapse or central fibrosis, which may account for the decrease in volume and mass (35) ; and molecular mutations switching the lesion toward a more aggressive type, which might explain the rapid growth.
In our study, the volume-DT of growing GGOs between the baseline and last CT scan ranged from 259 to 2196 days (median, 728.5 days; IQR, 460.5-952.5 days). This finding is in line with previous literature data (7, 25) , although the observed volume-DT was longer than that reported by Oda et al. (21) (mean, 486.4±368.6 days; range, 89-1583 days) using in-house semi-automated software. Such differences might be related to the different sample size and different study design, as we included only GGOs greater than or equal to 8 mm, and each lesion was examined during follow-up with the same scanner and same acquisition/reconstruction protocol.
Conversely, the volume-DTs and mass-DTs of growing GGOs in our study were shorter than those reported by Song et al. (20) . We attribute this difference to the different population (in their study, only patients without a history of previous malignancy were included) and the different sample size (only histologically confirmed GGOs greater than or equal to 8 mm were included in our study).
In contrast to the literature data (20, 21), we did not observe statistically significant differences between the DTs of part-solid GGOs and DTs of pure GGOs. With regard to mass-DT, the lack of a significant difference between pure and part-solid GGOs, as classified on the baseline CT, can be explained because some part-solid lesions in our series Data are presented as number (%), mean±standard deviation, or median (range). GGO, focal ground-glass opacity. *Changes from baseline to the last CT scan for growing lesions.
showed a reduction in mean CT attenuation during the follow-up (Fig. 7) . This finding might be related to a difference in volumetric growth between the ground-glass and the solid component. In fact, if the growth of the ground-glass component in a part-solid GGO is greater than the growth of the solid component, it might reduce mean CT attenuation. Furthermore, two of the fastest growing lesions included in our study were pure at the baseline CT but developed a solid component during the follow-up (Figs. 5, 6) . Nevertheless, our study demonstrated that DT may provide information on GGO aggressiveness because the volume-DTs and mass-DTs of IA were significantly shorter than those of MIA and AIS.
In contrast to our data, Song et al. (20) found no significant difference in median volume-DT and mass-DT among AIS, MIA, and IA. We attribute this difference to the different patients and GGO selection.
This study had several limitations. First, it was performed retrospectively, and the time intervals between two consecutive follow-up CT scans were heterogeneous because no specific recommendations for the management of GGOs were available at the time of each CT examination and only thin-section CTs (1 mm thick) were selected. Second, only a small number of GGOs were included because the inclusion criteria were quite strict. Third, the lesion size was not small (27.3% were greater than 3 cm at the baseline CT), although a larger size may have reduced the variability of the measurements. Fourth, only the resected GGOs histologically proven to be adenocarcinomas were analyzed; therefore, nonresected lesions were not represented in our data. Fifth, more than 50% of our patients had a history of malignancy; although this group has a risk factor for fast-growing GGOs, we believe that it more appropriately represents daily clinical practice. Sixth, CT scans were performed without spirometric control of lung volume; however, respiratory gating is not easy to apply in clinical settings. Seventh, the 3D software used in our study did not have a dedicated vessel extraction function; therefore, the small vessels located within GGO lesions were not excluded during the segmentation process. However, the vessels contiguous to lesion contours were removed with the manual editing tool.
In conclusion, pulmonary adenocarcinomas presenting as GGOs show heterogeneous growth patterns with a trend toward a progressive increase in size over time. Despite their drawbacks, the calculation of volume-DT and mass-DT in GGOs may be useful for predicting tumor aggressiveness.
